Order Article Reprints

Alqifari SF, Gari MH, Guo JJ, Alamin S, Esmail AK, Esmail AK, Hamad HR, Aljabri A, Alatawi AM, Albishi LA, et al. Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023. Diseases. 2025; 13(7):208. https://doi.org/10.3390/diseases13070208

Alqifari, Saleh F., Musaab Habibulla Gari, Jeff J. Guo, Shoroq Alamin, Aya K. Esmail, Abdullah K. Esmail, Heba R. Hamad, Ahmed Aljabri, Amirah M. Alatawi, Laila A. Albishi, and et al. 2025. "Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023" Diseases 13, no. 7: 208. https://doi.org/10.3390/diseases13070208

Alqifari, S. F., Gari, M. H., Guo, J. J., Alamin, S., Esmail, A. K., Esmail, A. K., Hamad, H. R., Aljabri, A., Alatawi, A. M., Albishi, L. A., Alraddadi, M. O., & Hetta, H. F. (2025). Descriptive Analysis of Reported Adverse Events Associated with Vitiligo Medications Using FDA Adverse Event Reporting System (FAERS) Databases 2013–2023. Diseases, 13(7), 208. https://doi.org/10.3390/diseases13070208